Drug-Associated Insomnia: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System

Similar research 5

1. Real-World Study of Adverse Events Associated with Gepant Use in Migraine Treatment Based on the VigiAccess and U.S. Food and Drug Administration’s Adverse Event Reporting System Databases Frontiers in Pharmacology · 2024
2. A Real-World Disproportionality Analysis of Avacopan in Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System Pharmacology Research & Perspectives · 2025
3. Adverse Event Reporting of Four Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: A Real-World Study Based on the FDA Adverse Event Reporting System Frontiers in Pharmacology · 2024
4. Evaluating the Safety Profile of Alpha-1 Blockers, 5-Alpha-Reductase Inhibitors, and PDE5 Inhibitors for BPH: A Disproportionality Analysis of Real-World Adverse Events Based on FDA Adverse Event Reporting System The Aging Male · 2026
5. Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data Pharmaceuticals · 2026